ACTINIUM-225, AC-225
Intended use: This is alpha-emitting radionuclide and short-lived product of its dissolution, bismuth-213 (46 minutes); these substances are promising for the treatment of various oncological diseases by means of radiotherapy.
Specifications of ACTINIUM-225, AC-225 |
|
---|---|
Chemical form |
Powder or solution of nitrate Ac-225 |
Radiation type |
α, β |
Half-life |
10 days |
Relative activity |
With no vehicle - 5.8 * 104 Ci/g |
Radionuclide purity |
Ra-225 <0.02 Ra-224 <0.02 Th-229 <0.007 Amount of fissionable isotopes: <0.0006 |
Intended use: Sodium iodide is used in brachytherapy of cancer (prostate and brain), to estimate the glomerular filtration rate and to diagnose deep vein thrombosis, and is also used extensively in the radioimmunoassay.
Specifications of SODIUM IODIDE, I-125 |
|
---|---|
Appearance |
Transparent, non-colored fluid |
pH |
8-11 |
Radionuclide purity |
˃99.9999% |
Radiochemical purity |
99.20% |
Half-life |
59.408 days |
Packing |
From 18.5 GBq |
Indication: Diagnostics and thyroid gland treatment: for an evaluation of thyroid gland function, scanning and scintigraphy of thyroid gland at various diseases, including for diagnostics of infringement of thyroid gland functions, and also small-celled cancer of a thyroid gland and metastasises. With a view of therapy, Sodium iodide I-131 is used for thyrotoxicosis treatment and metastatic cancer of a thyroid gland.
Typical specification of SODIUM IODIDE I-131 |
|
---|---|
Appearance |
Colorless, transparent solution |
pH |
7.0-12.0 |
Radionuclide purity |
not more 0.01 % from activity of I-131 iodide for manufacturing date |
Radiochemical purity |
no less than 95% |
Expiry |
not more than 15 days |
Half-value period |
8.02 days |
Activity |
1 GBq, 2GBq |
Intended use: Treatment of neuroendocrine tumors with metastases. The drug is intended for IV injections. The patient is also treated with a protective drug to reduce the radiation exposure. The drug has a potent effect in destroying the cancer cells. In some cases, a full recovery occurs, but Lu-177 is mainly used to relieve clinical manifestations of cancer disease.
Specification of LUTETIUM CHLORIDE, LU-177 |
|
---|---|
Chemical form |
Lutetium chloride, solution in hydrochloric acid 0.04 M |
Half-life |
6.734 days |
Radiochemical purity |
≥99% |
Relative activity |
≥ 50 Ci/mg |
Intended use: The Mo-99 isotope is the parent isotope in the Tc-99m generator, which is used in the diagnosis of oncological diseases to visualize the skeleton and cardiac muscle, as well as to visualize the brain, the thyroid gland, the lungs (perfusion and ventilation), the gallbladder, the bone marrow, as well as the salivary and lacrimal glands.
Specification of MOLYBDENUM-99, MO-99 |
|
---|---|
Half-life |
66.02 hours |
рН |
7-10 |
Radionuclide purity |
≥ 95% |
Relative activity |
≥ 27 Ci/mg |
Intended use: Р-32 is used to diagnose brain tumors, intraocular tumors, breast tumors and some others. P-32 can be used to determine the velocity of blood flow, total volume of red blood cells, amount of circulating blood in cardiovascular diseases, and to diagnose the hematological diseases. Р-32 is considered to be the best known means for treatment of polycythemia, with less efficacy in myeloid leukemia. Moreover, radioactive phosphorus is also used in certain malignant neoplasms: Ewing Sarcoma, osteogenic sarcoma, gallbladder cancer, and bone metastases of breast cancer.
Specifications of PHOSPHORUS-32, Р-32 |
|
---|---|
Chemical form |
Orthophosphoric acid, solution in hydrochloric acid 0.04 M |
Half-life |
14.26 days |
рН |
6-7 |
Radionuclide purity |
≥99.99% |
Relative activity |
≥ 8400 Ci/mmol |
Indication: Used in oncology with the aim of a persistent reduction in the intensity of the pain syndrome, caused by the presence of metastatic damage bones and for rheumatic patients with severe pain syndrome. Also Sm-153 is very effective in the diagnosis and treatment of prostate and breast cancer.
Typical specification of Sm-153 |
|
---|---|
Half-value period |
46,27 hours |
рН |
5-7 |
Radionuclide purity |
not less than 99,99% |
Activity |
not less than 240 MBq/ml |
Intended use: Sr-89 is one of the most effective modern treatment modality, which is used for palliative care in patients with metastatic diasese of prostate, breast, kidneys, and lungs. Sr-89 is also used as an alternative method (or as a additional treatment method combined with external radiation therapy) to relieve the pain syndrome in bone cancer.
Specifications of STRONTIUM CHLORIDE, SR-89 |
|
---|---|
Chemical form |
Strontium chloride, solution in hydrochloric acid |
Half-life |
50.5 days |
Concentration activity |
33.3-40.7 MBc/ml |
Relative activity |
˃ 300 Ci/g |
Indication: Tc-99m generator is intended for multiple production of sterile pyrogen-free sodium pertechnetate in physiological saline solution (0,9% NaCl).
Typical specification of Tc-99m generator |
|
---|---|
Parent Isotope activity |
4 GBq, 6 GBq, 8 GBq, 11 GBq, 19 GBq |
Appearance |
Colorless, transparent solution |
Radioactive concentration |
74-3700 MBq/ml |
pH |
4,0-7,0 |
Radiochemical purity |
not less than 99.0% |
Expiry |
15 days from the production date |
Generator weight |
16 kg (weight of generator including the package) |
Intended use: This radionuclide is often used to diagnose coronary heart disease and other heart diseases. This is the most commonly used replacement for Tc-99m. Tl-201 was the main substance for the nuclear cardiography. Moreover, this radionuclide is still being used for stress tests in patient with high risk of coronary heart disease.
Specifications of THALLIUM-201, Tl-201 |
|
---|---|
Chemical form |
TL-201, with no vehicle in 0.9% saline solution |
Half-life |
72.912 hours |
рН |
5-7 |
Radionuclide purity |
≥98% |
Relative activity |
≥ 10 mCi/ml |
Intended use: W-188 is a parent isotope for the production of W-188/Re-188 generators, designed to produce sterile apyrogenic sodium perrhenate Na188ReO4), which, combined with special kits, is used to synthesize the radiopharmaceutical agents for cancer therapy with simultaneous visualization of the distribution of the agent in the human body.
Specifications, SODIUM TUNGSTATE W-188 |
|
---|---|
Chemical form |
Sodium tungstate solution in NaOH (0.5-2.0 mol/l) |
Half-life |
69.78 days |
Relative activity |
No more than 3.5 Ci/g |
XENON-133, XE-133
Intended use: In clinical settings, Xe-133 is used for radioisotope diagnostics in the form of an air-xenon mixture and an isotonic solution. Air-xenon (Xe-133) mixture is used as a radioactive indicator in the study of regional pulmonary ventilation, to assess the patency of subarachnoid space and to determine the level and degree of blockade of CSF pathways of the spinal cord. Sterile isotonic solution with Xe-133 is used for quantitative assessment of blood flow in various organs and tissues. In clinical settings, this technique has widely used in evaluation of regional cerebral bloodflow, muscular bloodflow, coronary blood flow, as well as regional bloodflow in the lungs.
Specifications of XENON-133, XE-133 |
|
---|---|
Chemical form |
Gas |
Half-life |
5.27 days |